目的:评价短期使用吸入型糖皮质激素-普米克(布地奈德)联用喘乐宁气雾剂(沙丁胺醇)的有效性和安全性。方法:88例未达到控制的支气管哮喘者接受吸入中等剂量普米克和喘乐订治疗,于治药前、治疗后1、3、6个月监测最高呼气流速(PEFR)值动态变化。结果:治疗后1、3、6个月PEFR有明显改善;上述剂量短期内使用安全可靠。结论:普米克联用喘乐宁治疗哮喘临床疗效显著、安全性好,是目前治疗哮喘的最佳方案之一。 PURPOSE: To evaluate the efficacy and safety of short-term inhaled glucocorticoid-pulimy (budesonide) in combination with salbutamol aerosol (salbutamol). Methods: A total of 88 patients with bronchial asthma who did not reach the control were enrolled in the moderate dose of Pulmicort and Letrozole, and their peak expiratory flow (PEFR) values ​​were monitored before treatment and 1, 3, and 6 months after treatment. Results: PEFR at 1, 3, and 6 months after treatment was significantly improved. The above dosage was safe and reliable in short term. Conclusion: Pulmicortes with salbutamol in the treatment of asthma clinical significant effect, good safety, is currently the best treatment of asthma, one of the programs.